E
Translational Development Acquisition Corp. TDAC
$10.60 $0.000.00% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2025 09/30/2025 06/30/2025 03/31/2025 12/31/2024
Net Income -3.87% 2.27% 9.45% 18,638.75% 86.95%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 6.17% -1.59% -0.76% -1,396.73% --
Change in Net Operating Assets -64.17% 152.21% -56.99% 117.01% -3,372.60%
Cash from Operations -33.26% 48.57% 26.04% 71.44% -1,902.47%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued 0.00% -- -- -- -31.75%
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- 91,614.67%
Cash from Financing 0.00% -- -- -- 90,939.01%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -246.22% 106.95% 26.04% -208.17% 40.86%